A detailed history of Farther Finance Advisors, LLC transactions in Artivion, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 90 shares of AORT stock, worth $2,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 78 15.38%
Holding current value
$2,569
Previous $1.99 Million 20.71%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$24.33 - $28.46 $291 - $341
12 Added 15.38%
90 $2.4 Million
Q2 2024

Jul 31, 2024

BUY
$19.62 - $25.65 $784 - $1,026
40 Added 105.26%
78 $1.99 Million
Q1 2024

May 13, 2024

BUY
$16.7 - $21.63 $300 - $389
18 Added 90.0%
38 $805,000
Q4 2023

Feb 14, 2024

BUY
$12.33 - $18.83 $234 - $357
19 Added 95.0%
39 $697,000
Q1 2023

May 13, 2024

SELL
$11.74 - $14.12 $223 - $268
-19 Reduced 48.72%
20 $262,000
Q4 2022

Sep 11, 2023

BUY
$10.01 - $13.9 $200 - $278
20 New
20 $242,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.15B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.